ReviewDrugs2013

Lenalidomide: a review of its use in patients with transfusion-dependent anaemia due to low- or intermediate-1-risk myelodysplastic syndrome associated with 5q chromosome deletion.

Yahiya Y Syed et al.PubMed ↗Publisher ↗

No numbers read from the abstract.